“Deciding to engage Medic Pro was the best decision we could have made! They have been extremely easy to work with… We recommend Medic Pro without hesitation.”
Managing Director – High-end device manufacturer, United States
Get regulatory updates and commentary by signing up to our newsletter
PROFESSIONAL
We aim to deliver robust regulatory support allowing our clients to focus on growing their business.
EXPERIENCED
Our broad experience with a range of products and clients enables us to proficiently address most regulatory challenges.
KNOWLEDGEABLE
We offer expert regulatory advice that will bring your products to market without delay.
Medic Pro Services:
Tobacco Products Directive
We provide a wide-range of TPD services including notification submissions, expert regulatory advice and analytical testing services to help companies comply with the EU e-cigarette regulations.
Cannabidiol
We offer a number of regulatory services to help importers and manufacturers of cannabidiol (CBD) products comply with the emerging European CBD regulations.
Cosmetics: Take an online course
Watch our corporate video
From the Blog
Despite the fact that UK is no longer a member of the EU, the Food Standards Agency (FSA) have announced a deadline for the CBD industry to comply with EU regulations relating to novel foods.
A study in the US has found that almost 70% of CBD products bought online had inaccurate labelling. Research by the University of Pennsylvania showed that CBD products sold from online US stores did not have the CBD content they claimed they had.
Earlier this year, the UK Parliament engaged in a discussion with government departments and the vape industry on a variety of hot vape-related topics. So what did they talk about and what did we learn from the proceedings?
We have covered 4 key learnings from the meetings in two parts. Part 1 was published in May. This is part 2.
Over the past few months the UK Parliament has engaged in a discussion with government departments and the vape industry on a variety of hot topics. So what did they talk about and what did we learn from the proceedings? Here, we cover the key learnings from the meetings in two parts. This is Part 1.